These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9116382)

  • 1. Talking effect and white coat phenomenon in hypertensive patients.
    Le Pailleur C; Vacheron A; Landais P; Mounier-Véhier C; Feder JM; Montgermont P; Jais JP; Metzger JP
    Behav Med; 1996; 22(3):114-22. PubMed ID: 9116382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talking effect and "white coat" effect in hypertensive patients: physical effort or emotional content?
    Le Pailleur C; Montgermont P; Feder JM; Metzger JP; Vacheron A
    Behav Med; 2001; 26(4):149-57. PubMed ID: 11409217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White-coat hypertension and sex.
    James GD; Marion R; Pickering TG
    Blood Press Monit; 1998 Oct; 3(5):281-287. PubMed ID: 10212367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'White coat' hypertension in children.
    Hornsby JL; Mongan PF; Taylor AT; Treiber FA
    J Fam Pract; 1991 Dec; 33(6):617-23. PubMed ID: 1744607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of talking, reading, and silence on the "white coat" phenomenon in hypertensive patients.
    Le Pailleur C; Helft G; Landais P; Montgermont P; Feder JM; Metzger JP; Vacheron A
    Am J Hypertens; 1998 Feb; 11(2):203-7. PubMed ID: 9524049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological constructs associated with emotional blood pressure response and white coat phenomenon.
    Crippa G; Bertoletti P; Bettinardi O; Calandra G; Carrara GC
    Ann Ital Med Int; 2000; 15(4):250-4. PubMed ID: 11202625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension].
    Mayoral E; Lapetra J; Santos JM; López A; Ruiz J; Cayuela A
    Med Clin (Barc); 1997 Apr; 108(13):485-9. PubMed ID: 9235424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["White-coat" effect in 35 consecutive patients with hypertension. Quantification method, role of physician-patient dialogue].
    Le Pailleur C; Feder JM; Baubion N; Landais P; el Hasnaoui A; Montgermont P; Metzger JP; Heulin A; Mounier-Vehier C; Vacheron A
    Arch Mal Coeur Vaiss; 1993 Apr; 86(4):427-33. PubMed ID: 8239870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
    Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
    J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of physician-patient dialogue in the "white-coat" effect in arterial hypertension. Reproducibility during the consultation. Existence despite of treatment].
    Le Pailleur C; Landais P
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):135-8. PubMed ID: 8024225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White-coat hypertension in adults and children.
    Verdecchia P
    Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term changes in clinic blood pressure in patients with white-coat hypertension.
    Saito I; Murata K; Tsujioka M; Kawabe H; Saruta T
    Blood Press Monit; 1998 Apr; 3(2):97-100. PubMed ID: 10212337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J; Balazovjech I; Lánská V
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
    Larkin KT; Schauss SL; Elnicki DM; Goodie JL
    J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.